Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Gallo

Showing results (861-870 of 1,331) with videos related to

Pageof 134
Sort By:
International Journal of Oncology|July 13, 1999
The impact of schedule on acute toxicity and dose-intensity of high-dose chemotherapy with epirubicin and cyclophosphamide plus colony stimulating factors in advanced breast cancerS De Placido, R Lauria, C Carlomagno, et al.
Planta Medica|April 9, 2014
The anti-promyelocytic leukemia mode of action of two endophytic secondary metabolites unveiled by a proteomic approachMargareth B C Gallo, Miranda J S Falso, Fernanda Balem, et al.
The Journal of Clinical Investigation|July 1, 1984
Identification of the human T cell lymphoma virus in B cell lines established from patients with adult T cell leukemiaD L Mann, J Clark, M Clarke, et al.
Science (New York, N.Y.)|March 13, 1992
Identification of a major growth factor for AIDS-Kaposi's sarcoma cells as oncostatin MB C Nair, A L DeVico, S Nakamura, et al.
Anales De Medicina Interna (Madrid, Spain : 1984)|December 9, 1998
[Hospital detoxification unit: 4-year experience. Treatment and infections]C Gutiérrez del Río, M Casanueva Gutiérrez, B de la Fuente García, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1985
3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitroH Mitsuya, K J Weinhold, P A Furman, et al.
Annals of Internal Medicine|March 1, 1985
Seroepidemiology of human T-lymphotropic virus type III among homosexual men with the acquired immunodeficiency syndrome or generalized lymphadenopathy and among asymptomatic controls in BostonJ E Groopman, K H Mayer, M G Sarngadharan, et al.
Molecular Pharmacology|June 1, 1994
A binding site model and structure-activity relationships for the rat A3 adenosine receptorP J van Galen, A H van Bergen, C Gallo-Rodriguez, et al.
Journal of Virological Methods|May 1, 1985
Radioimmunoassay and enzyme-linked immunoassay of antibodies to the core protein (P24) of human T-lymphotropic virus (HTLV III)A R Neurath, N Strick, P Sproul, et al.
Journal of the American Heart Association|September 6, 2021
Variability in Daily Eating Patterns and Eating Jetlag Are Associated With Worsened Cardiometabolic Risk Profiles in the American Heart Association Go Red for Women Strategically Focused Research NetworkNour Makarem, Dorothy D Sears, Marie-Pierre St-Onge, et al.
Pageof 134

Showing results (861-870 of 1,331) with videos related to

Sort By:
Pageof 134
International Journal of Oncology|July 13, 1999
The impact of schedule on acute toxicity and dose-intensity of high-dose chemotherapy with epirubicin and cyclophosphamide plus colony stimulating factors in advanced breast cancerS De Placido, R Lauria, C Carlomagno, et al.
Planta Medica|April 9, 2014
The anti-promyelocytic leukemia mode of action of two endophytic secondary metabolites unveiled by a proteomic approachMargareth B C Gallo, Miranda J S Falso, Fernanda Balem, et al.
The Journal of Clinical Investigation|July 1, 1984
Identification of the human T cell lymphoma virus in B cell lines established from patients with adult T cell leukemiaD L Mann, J Clark, M Clarke, et al.
Science (New York, N.Y.)|March 13, 1992
Identification of a major growth factor for AIDS-Kaposi's sarcoma cells as oncostatin MB C Nair, A L DeVico, S Nakamura, et al.
Anales De Medicina Interna (Madrid, Spain : 1984)|December 9, 1998
[Hospital detoxification unit: 4-year experience. Treatment and infections]C Gutiérrez del Río, M Casanueva Gutiérrez, B de la Fuente García, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1985
3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitroH Mitsuya, K J Weinhold, P A Furman, et al.
Annals of Internal Medicine|March 1, 1985
Seroepidemiology of human T-lymphotropic virus type III among homosexual men with the acquired immunodeficiency syndrome or generalized lymphadenopathy and among asymptomatic controls in BostonJ E Groopman, K H Mayer, M G Sarngadharan, et al.
Molecular Pharmacology|June 1, 1994
A binding site model and structure-activity relationships for the rat A3 adenosine receptorP J van Galen, A H van Bergen, C Gallo-Rodriguez, et al.
Journal of Virological Methods|May 1, 1985
Radioimmunoassay and enzyme-linked immunoassay of antibodies to the core protein (P24) of human T-lymphotropic virus (HTLV III)A R Neurath, N Strick, P Sproul, et al.
Journal of the American Heart Association|September 6, 2021
Variability in Daily Eating Patterns and Eating Jetlag Are Associated With Worsened Cardiometabolic Risk Profiles in the American Heart Association Go Red for Women Strategically Focused Research NetworkNour Makarem, Dorothy D Sears, Marie-Pierre St-Onge, et al.
Pageof 134